Literature DB >> 30205790

Medicinal Plants and Atherosclerosis: A Review on Molecular Aspects.

Sajedeh Gholipour1, Robert D E Sewell2, Zahra Lorigooini1, Mahmoud Rafieian-Kopaei1.   

Abstract

Atherosclerosis is an inflammatory vascular disease that is characterized by progressive accumulation of cholesterol in the arterial walls and it is a major cause of cardiovascular disease. Issues related to the side effects of synthetic drugs have in recent times, led to the misuse of drugs, a lack of patient consultations, and consequently, a disruption in meticulous disease control. Therefore, a new insight into medicinal plants has recently emerged and much research has been conducted on these herbs in an attempt to prepare novel naturally based drugs. The aim of this review article was to scrutinize the molecular mechanisms of medicinal plants possessing effectiveness against atherosclerosis. To conduct the review, electronic searches were performed to retrieve potentially relevant publications, indexed within internet databases and reference textbooks concerning the effects and underlying molecular mechanisms of plants or their constituents used to treat atherosclerosis. Overall, medicinal plants facilitate atherosclerosis treatment through a variety of mechanisms which include the regulation of expression of inflammatory factors, stimulation of peroxisome proliferator-activated receptors (PPARs), inhibition of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMG-CoA reductase), promotion of ATP-binding cassette transporter A1 (ABCA1) as well as ATP-binding cassette transporter G (ABCG), facilitation of adiponectin activity, reduction of sterol regulatory element-binding proteins (SREBPs) and antioxidant activity. An increased perception of these herbal mechanistic links is an important prelude to the design of novel plant based drugs. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Atherosclerosis; HMG-CoA reductase; cholesterol; medicinal plants; molecular mechanisms; vascular disease.

Mesh:

Substances:

Year:  2018        PMID: 30205790     DOI: 10.2174/1381612824666180911121525

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  4 in total

1.  MiR-128-3p inhibits vascular smooth muscle cell proliferation and migration by repressing FOXO4/MMP9 signaling pathway.

Authors:  Chuan Qu; Xin Liu; Yan Guo; Yuhong Fo; Xiuhuan Chen; Jining Zhou; Bo Yang
Journal:  Mol Med       Date:  2020-11-25       Impact factor: 6.354

2.  Evaluation of the haematinic, antioxidant and anti-atherosclerotic potential of Momordica charantia in cholesterol-fed experimental rats.

Authors:  Silvanus Olu Innih; Ikechi Gerald Eze; Kingsley Omage
Journal:  Toxicol Rep       Date:  2022-03-31

3.  A Network-Guided Approach to Discover Phytochemical-Based Anticancer Therapy: Targeting MARK4 for Hepatocellular Carcinoma.

Authors:  Sarfraz Ahmed; Mohammad Mobashir; Lamya Ahmed Al-Keridis; Nawaf Alshammari; Mohd Adnan; Mohammad Abid; Md Imtaiyaz Hassan
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

Review 4.  Zimbro (Juniperus communis L.) as a Promising Source of Bioactive Compounds and Biomedical Activities: A Review on Recent Trends.

Authors:  Ana C Gonçalves; José David Flores-Félix; Paula Coutinho; Gilberto Alves; Luís R Silva
Journal:  Int J Mol Sci       Date:  2022-03-16       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.